|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 105.1 USD | -0.83% |
|
+2.42% | +11.68% |
| 08:00am | NEW INDEPENDENT STUDIES CONTRADICT PMI'S OWN FINDINGS ON IQOS, L… | RE |
| 08:00am | Campaigners target Philip Morris' flagship heated tobacco US launch | RE |
By Colin Kellaher
Philip Morris International Inc. on Monday said it named Jorge Insuasty chief life-sciences officer, effective Jan. 15.
The tobacco company said Mr. Insuasty joins from Sanofi S.A., where most recently he was global franchise head of immunology, oncology and neurology for Sanofi Genzyme.
Philip Morris said Mr. Insuasty succeeds John O'Mullane, who is retiring.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
01-11-21 0950ET
| 1st Jan change | Capi. | |
|---|---|---|
| +11.68% | 163B | |
| +7.43% | 71.16B | |
| +13.92% | 22.63B | |
| +30.92% | 6.66B | |
| +115.00% | 2.94B | |
| -1.79% | 1.82B | |
| -2.39% | 1.73B | |
| -27.55% | 1.2B | |
| 0.00% | 636M | |
| +38.41% | 642M |
PHILIP MORRIS INTERNATIONAL, INC. 
